Go Pro

EUDA Health (EUDA) Competitors

EUDA Health logo
$14.62 -0.41 (-2.73%)
As of 08/28/2026 12:30 PM Eastern

EUDA vs. DOUG, ASPS, DUO, FTHM, and OPAD

Should you buy EUDA Health stock or one of its competitors? EUDA Health's main competitors and comparable companies include Douglas Elliman (DOUG), Altisource Portfolio Solutions (ASPS), Fangdd Network Group (DUO), Fathom (FTHM), and Offerpad Solutions (OPAD). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "real estate services" industry.

How does EUDA Health compare to Douglas Elliman?

EUDA Health (NASDAQ:EUDA) and Douglas Elliman (NYSE:DOUG) are both small-cap real estate companies, but which is the better investment? We will contrast the two businesses based on the strength of their media sentiment, valuation, analyst recommendations, profitability, earnings, dividends, risk and institutional ownership.

EUDA Health presently has a consensus target price of $55.00, indicating a potential upside of 276.20%. Given EUDA Health's stronger consensus rating and higher possible upside, equities analysts plainly believe EUDA Health is more favorable than Douglas Elliman.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
EUDA Health
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Douglas Elliman
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Douglas Elliman has higher revenue and earnings than EUDA Health.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
EUDA Health$6.82M6.41-$2.77MN/AN/A
Douglas Elliman$1.03B0.16$15.22M$0.1710.82

EUDA Health has a beta of 0.64, indicating that its stock price is 36% less volatile than the broader market. Comparatively, Douglas Elliman has a beta of 1.86, indicating that its stock price is 86% more volatile than the broader market.

Douglas Elliman has a net margin of 2.47% compared to EUDA Health's net margin of 0.00%. EUDA Health's return on equity of 0.00% beat Douglas Elliman's return on equity.

Company Net Margins Return on Equity Return on Assets
EUDA HealthN/A N/A N/A
Douglas Elliman 2.47%-19.16%-6.72%

4.4% of EUDA Health shares are owned by institutional investors. Comparatively, 59.6% of Douglas Elliman shares are owned by institutional investors. 9.6% of Douglas Elliman shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, EUDA Health had 1 more articles in the media than Douglas Elliman. MarketBeat recorded 3 mentions for EUDA Health and 2 mentions for Douglas Elliman. EUDA Health's average media sentiment score of 1.30 beat Douglas Elliman's score of 0.00 indicating that EUDA Health is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
EUDA Health
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Douglas Elliman
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

EUDA Health beats Douglas Elliman on 8 of the 14 factors compared between the two stocks.

How does EUDA Health compare to Altisource Portfolio Solutions?

EUDA Health (NASDAQ:EUDA) and Altisource Portfolio Solutions (NASDAQ:ASPS) are both small-cap real estate companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, media sentiment, valuation, risk, earnings, analyst recommendations and profitability.

Altisource Portfolio Solutions has higher revenue and earnings than EUDA Health.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
EUDA Health$6.82M6.41-$2.77MN/AN/A
Altisource Portfolio Solutions$170.98M0.37$1.62M-$0.99N/A

EUDA Health has a net margin of 0.00% compared to Altisource Portfolio Solutions' net margin of -5.93%. EUDA Health's return on equity of 0.00% beat Altisource Portfolio Solutions' return on equity.

Company Net Margins Return on Equity Return on Assets
EUDA HealthN/A N/A N/A
Altisource Portfolio Solutions -5.93%-1.69%1.31%

EUDA Health currently has a consensus target price of $55.00, suggesting a potential upside of 276.20%. Altisource Portfolio Solutions has a consensus target price of $8.00, suggesting a potential upside of 45.45%. Given EUDA Health's higher possible upside, equities research analysts clearly believe EUDA Health is more favorable than Altisource Portfolio Solutions.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
EUDA Health
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Altisource Portfolio Solutions
2 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
1 Strong Buy rating(s)
2.00

4.4% of EUDA Health shares are held by institutional investors. Comparatively, 41.4% of Altisource Portfolio Solutions shares are held by institutional investors. 19.1% of Altisource Portfolio Solutions shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

In the previous week, Altisource Portfolio Solutions had 1 more articles in the media than EUDA Health. MarketBeat recorded 4 mentions for Altisource Portfolio Solutions and 3 mentions for EUDA Health. Altisource Portfolio Solutions' average media sentiment score of 1.68 beat EUDA Health's score of 1.30 indicating that Altisource Portfolio Solutions is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
EUDA Health
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Altisource Portfolio Solutions
2 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

EUDA Health has a beta of 0.64, indicating that its stock price is 36% less volatile than the broader market. Comparatively, Altisource Portfolio Solutions has a beta of 0.27, indicating that its stock price is 73% less volatile than the broader market.

Summary

Altisource Portfolio Solutions beats EUDA Health on 8 of the 14 factors compared between the two stocks.

How does EUDA Health compare to Fangdd Network Group?

EUDA Health (NASDAQ:EUDA) and Fangdd Network Group (NASDAQ:DUO) are both small-cap real estate companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, risk, analyst recommendations, dividends, media sentiment, earnings, institutional ownership and valuation.

Company Net Margins Return on Equity Return on Assets
EUDA HealthN/A N/A N/A
Fangdd Network Group N/A N/A N/A

EUDA Health presently has a consensus price target of $55.00, indicating a potential upside of 276.20%. Given EUDA Health's stronger consensus rating and higher possible upside, research analysts clearly believe EUDA Health is more favorable than Fangdd Network Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
EUDA Health
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Fangdd Network Group
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

4.4% of EUDA Health shares are owned by institutional investors. 35.2% of Fangdd Network Group shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

EUDA Health has higher earnings, but lower revenue than Fangdd Network Group.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
EUDA Health$6.82M6.41-$2.77MN/AN/A
Fangdd Network Group$354.82M0.10-$12.11MN/AN/A

In the previous week, Fangdd Network Group had 2 more articles in the media than EUDA Health. MarketBeat recorded 5 mentions for Fangdd Network Group and 3 mentions for EUDA Health. EUDA Health's average media sentiment score of 1.30 beat Fangdd Network Group's score of 1.11 indicating that EUDA Health is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
EUDA Health
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Fangdd Network Group
1 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

EUDA Health has a beta of 0.64, suggesting that its share price is 36% less volatile than the broader market. Comparatively, Fangdd Network Group has a beta of 3.18, suggesting that its share price is 218% more volatile than the broader market.

Summary

EUDA Health beats Fangdd Network Group on 7 of the 11 factors compared between the two stocks.

How does EUDA Health compare to Fathom?

Fathom (NASDAQ:FTHM) and EUDA Health (NASDAQ:EUDA) are both small-cap real estate companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, media sentiment, valuation, risk, profitability, analyst recommendations, earnings and institutional ownership.

Fathom currently has a consensus price target of $2.50, indicating a potential upside of 266.68%. EUDA Health has a consensus price target of $55.00, indicating a potential upside of 276.20%. Given EUDA Health's higher probable upside, analysts plainly believe EUDA Health is more favorable than Fathom.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Fathom
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
1 Strong Buy rating(s)
2.50
EUDA Health
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

EUDA Health has a net margin of 0.00% compared to Fathom's net margin of -6.27%. EUDA Health's return on equity of 0.00% beat Fathom's return on equity.

Company Net Margins Return on Equity Return on Assets
Fathom-6.27% -75.89% -33.25%
EUDA Health N/A N/A N/A

In the previous week, EUDA Health had 2 more articles in the media than Fathom. MarketBeat recorded 3 mentions for EUDA Health and 1 mentions for Fathom. Fathom's average media sentiment score of 1.89 beat EUDA Health's score of 1.30 indicating that Fathom is being referred to more favorably in the media.

Company Overall Sentiment
Fathom Very Positive
EUDA Health Positive

EUDA Health has lower revenue, but higher earnings than Fathom.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Fathom$406.93M0.06-$20.31M-$0.80N/A
EUDA Health$6.82M6.41-$2.77MN/AN/A

55.5% of Fathom shares are owned by institutional investors. Comparatively, 4.4% of EUDA Health shares are owned by institutional investors. 16.4% of Fathom shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Fathom has a beta of 2.21, suggesting that its stock price is 121% more volatile than the broader market. Comparatively, EUDA Health has a beta of 0.64, suggesting that its stock price is 36% less volatile than the broader market.

Summary

EUDA Health beats Fathom on 8 of the 15 factors compared between the two stocks.

How does EUDA Health compare to Offerpad Solutions?

Offerpad Solutions (NYSE:OPAD) and EUDA Health (NASDAQ:EUDA) are both small-cap real estate companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, profitability, valuation, analyst recommendations, dividends, media sentiment, earnings and institutional ownership.

Offerpad Solutions has a beta of 2.48, suggesting that its stock price is 148% more volatile than the broader market. Comparatively, EUDA Health has a beta of 0.64, suggesting that its stock price is 36% less volatile than the broader market.

39.4% of Offerpad Solutions shares are owned by institutional investors. Comparatively, 4.4% of EUDA Health shares are owned by institutional investors. 16.7% of Offerpad Solutions shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

EUDA Health has lower revenue, but higher earnings than Offerpad Solutions.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Offerpad Solutions$567.81M0.04-$46.38M-$10.24N/A
EUDA Health$6.82M6.41-$2.77MN/AN/A

EUDA Health has a net margin of 0.00% compared to Offerpad Solutions' net margin of -9.85%. EUDA Health's return on equity of 0.00% beat Offerpad Solutions' return on equity.

Company Net Margins Return on Equity Return on Assets
Offerpad Solutions-9.85% -99.08% -23.21%
EUDA Health N/A N/A N/A

Offerpad Solutions presently has a consensus target price of $24.83, indicating a potential upside of 463.11%. EUDA Health has a consensus target price of $55.00, indicating a potential upside of 276.20%. Given Offerpad Solutions' higher probable upside, equities analysts plainly believe Offerpad Solutions is more favorable than EUDA Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Offerpad Solutions
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
EUDA Health
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

In the previous week, EUDA Health had 3 more articles in the media than Offerpad Solutions. MarketBeat recorded 3 mentions for EUDA Health and 0 mentions for Offerpad Solutions. EUDA Health's average media sentiment score of 1.30 beat Offerpad Solutions' score of 1.00 indicating that EUDA Health is being referred to more favorably in the news media.

Company Overall Sentiment
Offerpad Solutions Positive
EUDA Health Positive

Summary

EUDA Health beats Offerpad Solutions on 7 of the 12 factors compared between the two stocks.

Get EUDA Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for EUDA and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding EUDA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

EUDA vs. The Competition

MetricEUDA HealthReal Estate Management & Development IndustryReal Estate SectorNASDAQ Exchange
Market Cap$43.76M$3.41B$5.66B$12.90B
Dividend YieldN/A4.35%6.33%11.28%
P/E RatioN/A14.5028.7725.45
Price / Sales6.4191.62128.3771.88
Price / CashN/A20.1134.6353.00
Price / Book-6.472.101.886.14
Net Income-$2.77M-$438.94M-$64.48M$348.86M
7 Day Performance10.67%-0.27%-0.40%-0.80%
1 Month Performance-25.28%0.37%0.45%4.13%
1 Year Performance-64.51%-8.46%11.25%15.17%

EUDA Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
EUDA
EUDA Health
2.4918 of 5 stars
$14.62
-2.7%
$55.00
+276.2%
-64.5%$43.76M$6.82MN/A2
DOUG
Douglas Elliman
0.3054 of 5 stars
$1.97
+4.5%
N/A-32.5%$170.87M$1.03B11.56930
ASPS
Altisource Portfolio Solutions
4.3658 of 5 stars
$5.50
+2.6%
$8.00
+45.5%
-52.0%$61.21M$182.50MN/A1,236
DUO
Fangdd Network Group
1.3227 of 5 stars
$0.69
+8.6%
N/A-59.8%$24.49M$50.74MN/A600
FTHM
Fathom
2.9384 of 5 stars
$0.72
+0.8%
$2.50
+248.2%
-65.7%$24.36M$420.48MN/A240

Related Companies and Tools


This page (NASDAQ:EUDA) was last updated on 8/30/2026 by MarketBeat.com Staff.
From Our Partners